A California Start-Up Wants to Cure Alzheimer's With Youthful Blood
Alkahest is performing patient trials to see if injecting plasma into Alzheimer's patients can mitigate the effects of the disease.
Gregory Logan-Graf is a researcher at Carnegie Mellon University, where he studies a protein called actin.
Alkahest is performing patient trials to see if injecting plasma into Alzheimer's patients can mitigate the effects of the disease.